Market Cap 15.95M
Revenue (ttm) 0.00
Net Income (ttm) -37.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 155,600
Avg Vol 625,798
Day's Range N/A - N/A
Shares Out 27.45M
Stochastic %K 33%
Beta 1.00
Analysts Sell
Price Target $4.00

Company Profile

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic reli...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 967 6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
Idkwhattonamemyself
Idkwhattonamemyself Sep. 13 at 7:26 AM
$CTXR I still think about this 99% loss. Ridiculous
0 · Reply
andy001
andy001 Sep. 12 at 10:40 AM
$CTXR Haters!!!
0 · Reply
np_stocks
np_stocks Sep. 11 at 4:54 PM
$CTXR what an awful company and awful management team. Shame on all them.
0 · Reply
Applebat
Applebat Sep. 6 at 3:34 PM
$CTXR it's all over but the crying now. they ran out of cash in November. they're $30 million in debt. they de-list in February. sales of Lymphir were dismal. some predatory big fish. going to come in and buy Lymphir. that will leave current shareholders holding an empty husk of a company. CTXR and CTOR won't exist in 6 months
1 · Reply
InvestorRelations_
InvestorRelations_ Sep. 5 at 9:09 AM
$CTXR they pay pumpers with YOUR money. Disgusting
0 · Reply
np_stocks
np_stocks Sep. 4 at 11:00 PM
$CTXR how about a Labor Day apology for all the false lies and false promises. If I were the CEO of this company I’d be ashamed of myself, ashamed of letting my employees down, ashamed of what I put my family through and I’d reach out to all you and provide regular updates and a timeline of what is to come. Shameful and a disgrace what this company has done. Everyone have a nice weekend besides this rat shit company. Mino-lok lol….yeah sure….
0 · Reply
focafoca99
focafoca99 Sep. 3 at 1:04 PM
$CTXR participated in two September investor conferences, with CEO Leonard Mazur presenting at H.C. Wainwright and Moody Capital. https://www.rapidticker.com/news/ctxr-citius-pharmaceuticals-to-participate-in-cf34bb
2 · Reply
uebersoldat
uebersoldat Aug. 31 at 2:09 PM
$CTXR This stock taught me the single most important rule in investing. NEVER invest more than you are willing to lose. My personal story is that I dumped a pretty good bonus check into this stock in 2021 and it's lost 90% of its value since. Thank goodness I never invested more. One of my most expensive gambles of my life, and it hangs by a thread.
1 · Reply
HypnoTrader
HypnoTrader Aug. 28 at 11:39 AM
$CTXR $CTOR pump and dump is still going on. Hemmoraging cash. Latest sales numbers mean they probably won't be able to unlock revenue dependent additional financing from May 2026 agreement. That funding deal was horribly dilutive and not sufficient to get to profitability. Now, matters look much worse.
0 · Reply
np_stocks
np_stocks Aug. 27 at 4:40 PM
$CTXR stay away and invest in spacex / Nvidia. Way better companies and safer with your hard earned money. This ceo sucks and a lot of people know it! Lots of false promises….
0 · Reply
Latest News on CTXR
Citius Pharmaceuticals Quarterly report: Q3 2026

Aug 14, 2026, 7:00 AM EDT - 4 weeks ago

Citius Pharmaceuticals Quarterly report: Q3 2026


Citius Pharmaceuticals Earnings release: Q3 2026

Aug 14, 2026, 7:00 AM EDT - 4 weeks ago

Citius Pharmaceuticals Earnings release: Q3 2026


Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright

2026-05-18T13:00:56.000Z - 3 months ago

Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright


Citius Pharmaceuticals Quarterly report: Q2 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

Citius Pharmaceuticals Quarterly report: Q2 2026


Citius Pharmaceuticals Earnings release: Q2 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

Citius Pharmaceuticals Earnings release: Q2 2026


Citius Pharmaceuticals receives $3.8M through NJEDA program

2026-02-24T13:06:48.000Z - 6 months ago

Citius Pharmaceuticals receives $3.8M through NJEDA program


Citius Pharmaceuticals Proxy statement: Proxy Filing

Feb 24, 2026, 7:00 AM EST - 6 months ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Proxy statement: Proxy Filing

Feb 24, 2026, 7:00 AM EST - 6 months ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Earnings release: Q1 2026

Feb 13, 2026, 7:00 AM EST - 7 months ago

Citius Pharmaceuticals Earnings release: Q1 2026


Citius Pharmaceuticals Quarterly report: Q1 2026

Feb 13, 2026, 7:00 AM EST - 7 months ago

Citius Pharmaceuticals Quarterly report: Q1 2026


Citius Pharmaceuticals Earnings release: Q4 2025

Dec 23, 2025, 7:00 AM EST - 8 months ago

Citius Pharmaceuticals Earnings release: Q4 2025


Citius Pharmaceuticals Annual report: Q4 2025

Dec 23, 2025, 7:00 AM EST - 8 months ago

Citius Pharmaceuticals Annual report: Q4 2025


Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year

2025-08-12T20:36:02.000Z - 1 year ago

Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year


Citius Pharmaceuticals Earnings release: Q3 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Citius Pharmaceuticals Earnings release: Q3 2025


Citius Pharmaceuticals Quarterly report: Q3 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Citius Pharmaceuticals Quarterly report: Q3 2025


Citius Pharmaceuticals Earnings release: Q2 2025

May 14, 2025, 12:00 AM EDT - 1 year ago

Citius Pharmaceuticals Earnings release: Q2 2025


Citius Pharmaceuticals Quarterly report: Q2 2025

May 14, 2025, 12:00 AM EDT - 1 year ago

Citius Pharmaceuticals Quarterly report: Q2 2025


Citius Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Quarterly report: Q1 2025

Feb 14, 2025, 12:00 AM EST - 1 year ago

Citius Pharmaceuticals Quarterly report: Q1 2025


Citius Pharmaceuticals Earnings release: Q1 2025

Feb 14, 2025, 12:00 AM EST - 1 year ago

Citius Pharmaceuticals Earnings release: Q1 2025


Citius Pharmaceuticals Proxy statement: Proxy Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Proxy statement: Proxy Filing

Jan 27, 2025, 7:00 AM EST - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Citius Pharmaceuticals Proxy statement: Proxy Filing

Jan 16, 2025, 7:00 AM EST - 1 year ago

Citius Pharmaceuticals Proxy statement: Proxy Filing


Idkwhattonamemyself
Idkwhattonamemyself Sep. 13 at 7:26 AM
$CTXR I still think about this 99% loss. Ridiculous
0 · Reply
andy001
andy001 Sep. 12 at 10:40 AM
$CTXR Haters!!!
0 · Reply
np_stocks
np_stocks Sep. 11 at 4:54 PM
$CTXR what an awful company and awful management team. Shame on all them.
0 · Reply
Applebat
Applebat Sep. 6 at 3:34 PM
$CTXR it's all over but the crying now. they ran out of cash in November. they're $30 million in debt. they de-list in February. sales of Lymphir were dismal. some predatory big fish. going to come in and buy Lymphir. that will leave current shareholders holding an empty husk of a company. CTXR and CTOR won't exist in 6 months
1 · Reply
InvestorRelations_
InvestorRelations_ Sep. 5 at 9:09 AM
$CTXR they pay pumpers with YOUR money. Disgusting
0 · Reply
np_stocks
np_stocks Sep. 4 at 11:00 PM
$CTXR how about a Labor Day apology for all the false lies and false promises. If I were the CEO of this company I’d be ashamed of myself, ashamed of letting my employees down, ashamed of what I put my family through and I’d reach out to all you and provide regular updates and a timeline of what is to come. Shameful and a disgrace what this company has done. Everyone have a nice weekend besides this rat shit company. Mino-lok lol….yeah sure….
0 · Reply
focafoca99
focafoca99 Sep. 3 at 1:04 PM
$CTXR participated in two September investor conferences, with CEO Leonard Mazur presenting at H.C. Wainwright and Moody Capital. https://www.rapidticker.com/news/ctxr-citius-pharmaceuticals-to-participate-in-cf34bb
2 · Reply
uebersoldat
uebersoldat Aug. 31 at 2:09 PM
$CTXR This stock taught me the single most important rule in investing. NEVER invest more than you are willing to lose. My personal story is that I dumped a pretty good bonus check into this stock in 2021 and it's lost 90% of its value since. Thank goodness I never invested more. One of my most expensive gambles of my life, and it hangs by a thread.
1 · Reply
HypnoTrader
HypnoTrader Aug. 28 at 11:39 AM
$CTXR $CTOR pump and dump is still going on. Hemmoraging cash. Latest sales numbers mean they probably won't be able to unlock revenue dependent additional financing from May 2026 agreement. That funding deal was horribly dilutive and not sufficient to get to profitability. Now, matters look much worse.
0 · Reply
np_stocks
np_stocks Aug. 27 at 4:40 PM
$CTXR stay away and invest in spacex / Nvidia. Way better companies and safer with your hard earned money. This ceo sucks and a lot of people know it! Lots of false promises….
0 · Reply
TheBeautifulGopher
TheBeautifulGopher Aug. 26 at 1:42 PM
$CTXR sensei is too dumb will have to short
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 25 at 6:36 PM
$CTXR Is ‘One to Watch’ https://ibn.fm/ojPbC
0 · Reply
GammaFlip
GammaFlip Aug. 25 at 5:29 PM
$CTXR next gen of bag holders incoming
0 · Reply
HypnoTrader
HypnoTrader Aug. 25 at 3:50 PM
$CTXR Breakdown of the Paid Promotion Campaign The Scale: Over $67.X,500 has been documented across 11 different stock newsletters and digital publishing platforms. [1] The Outlets: Paid contracts were issued to entities like BullsEye Alerts (compensated $25,500) and Momentum Media LLC / MarketTips (compensated $5,000 to date). [1] The X (Twitter) Push: Independent social media accounts are receiving flat rates (disclosing micro-payments around $300 per post) to post pre-formatted technical setups highlighting "breakout potential," "gap fills," and "short squeeze" narratives.
0 · Reply
TwongStocks
TwongStocks Aug. 25 at 3:24 PM
$CTXR Increase in price and volume today.... And there are paid pumpers on X right now 😂 https://x.com/sensei_fractal/status/2092243123485204804 From the post disclaimer --->"The Publisher has agreed to be paid $325 USD (before deduction of bank and PayPal charges and fees) to publish the Information on this Platform about Citius Pharmaceuticals Inc. (NASDAQ: CTXR) for a period beginning on 08/25/2026 and ending on 08/25/2026. " Volume spikes are almost never organic here.
0 · Reply
Cashflow62
Cashflow62 Aug. 25 at 3:24 PM
$CTXR Citius received a second extension on August 17, 2026, pushing their deadline to early next year so google says.......
0 · Reply
900fix
900fix Aug. 24 at 3:05 PM
$CTXR That last pump n dump really worked out again. Lenny has never learned. He's too dumb. He must keep the same dimwits around him. Everyone sees through these paid online adds. That and reporting on a Friday night. What a moron.
0 · Reply
RME47pilot
RME47pilot Aug. 24 at 1:35 PM
$CTXR I see a reverse split in CTXRs future. A very common theme with this company and management team.
1 · Reply
Heyongo
Heyongo Aug. 24 at 1:04 PM
$CTXR is this piece of trash going to be delisted and in OTC? If yes, when?
0 · Reply
yellowjacker
yellowjacker Aug. 21 at 9:23 PM
$CTXR Not much of reaction in after hours trading, but Monday morning the shorts could be looking to cover.
0 · Reply
TwongStocks
TwongStocks Aug. 21 at 8:43 PM
$CTXR Compliance deadline extended to Feb 8, 2027 https://www.sec.gov/Archives/edgar/data/1506251/000121390026092604/ea0302856-8k_citius.htm NOTE: Due to changes to NASDAQ rules 5815 & 5810, CTXR must regain compliance by the 2nd deadline to remain listed on NASDAQ. Failure to regain compliance with the bid price rule before Feb 8 will result in a delisting & suspension of trading. CTXR will not be allowed to stay on NASDAQ, even with an appeal.
0 · Reply
focafoca99
focafoca99 Aug. 21 at 8:29 PM
$CTXR extends its Nasdaq compliance deadline, receiving an extension to Feb 8, 2027 to meet the $1.00 bid price rule. https://www.rapidticker.com/news/ctxr-sec-filing-8960c8
0 · Reply